This site has been created to provide visitors with relevant and up-to-date information about pseudobulbar affect (PBA) and the STAR Trial.
Avanir Pharmaceuticals is conducting a research study in patients with PBA in numerous clinical sites in the U.S. testing the efficacy and safety of an investigational treatment known as Zenvia™ or AVP-923.
If you, or someone you know, are interested in participating in the STAR Trial, this site will also help you to locate the nearest clinical site where the STAR Trial is currently being conducted.
This site is updated regularly but we know that you might have questions. If you have any questions regarding the STAR Trial clinical site locations, please feel free to contact us.